Decentralized Clinical Trials in Italy: state of the art and future perspectives

Clinical trials are an essential source of high-quality evidence for the assessment efficacy and safety healthcare interventions. Nowadays main criticality traditional clinical trial model is perhaps need to improve patient selection management, in terms initial identification, recruitment retention. Digital technology offers operational solutions that can facilitate many activities involved investigation. Decentralized Trials (DCTs) could be a new option provides use remote instruments/methods/activities different stages trial, so range procedures (such as informed consent, medical visits, administration drug or device, measurement parameters, diagnostic testing etc.) moved from research hospital patient’s home. Also Italy interest DCTs progressively growing, thanks their potential benefits lead significant advantages not only patients, but also National Health Service country whole. It important this should act stimulus, prompting timely initiatives order promote regulate methodology conduct avoid risk that, while other countries will actively promotion leading DCTs, selected “control arm”.